Accredo Health Subsidiaries to Provide Specialty Pharmacy Services to Aetna U.S. Healthcare Members and Participating Physicians.Business Editors/Health & Medical Writers MEMPHIS Memphis, city, ancient Egypt Memphis (mĕm`fĭs), ancient city of Egypt, capital of the Old Kingdom (c.3100–c.2258 B.C.), at the apex of the Nile delta and 12 mi (18 km) from Cairo. , Tenn.--(BUSINESS WIRE)--June 6, 2000 Accredo Health, Incorporated (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ACDO ACDO Air Carrier District Office ACDO Assistant Command Duty Officer ) today announced that its principal subsidiaries, Hemophilia Health Services health services Managed care The benefits covered under a health contract , Inc. and Nova Factor, Inc., have been selected by Aetna U.S. Healthcare U.S. Healthcare is a now-defunct healthcare company. The logo had an apple. The merger with Aetna In 1996, the company merged with Aetna, calling it Aetna U.S. Healthcare. The U.S. Healthcare apple logo was next to the Aetna name, and U.S. Healthcare under it. U.S. (R) as a preferred distributor of injectable in·ject·a·ble adj. Capable of being injected. Used of a drug. n. A drug or medicine that can be injected. medications to Aetna U.S. Healthcare members and participating physicians. Terms of the Agreement were not disclosed. Commenting on the new Agreement, John R. ("Randy") Grow, President of Nova Factor, Inc. and Accredo Health, Incorporated, said, "We are pleased to expand our existing relationship with Aetna U.S. Healthcare and look forward to providing their members and participating physicians with the top quality services offered by Nova Factor and Hemophilia Health Services." Accredo Health, Incorporated and its subsidiaries, Hemophilia Health Services, Inc. and Nova Factor, Inc., provide specialized contract pharmacy and related services pursuant to agreements with biopharmaceutical manufacturers relating to the treatment of patients with certain chronic diseases. Hemophilia Health Services, located in Nashville, Tennessee, is a national joint commission accredited accredited recognition by an appropriate authority that the performance of a particular institution has satisfied a prestated set of criteria. accredited herds cattle herds which have achieved a low level of reactors to, e.g. healthcare company dedicated exclusively to the disease management of hemophilia and related bleeding disorders. Nova Factor, located in Memphis, Tennessee, specializes in injectable biopharmaceuticals that require temperature control and are prescribed for chronically or seriously ill people. Through their therapy-specific team approach, Nova Factor and Hemophilia Health Services provide pharmaceutical care management, dispensing, nationwide distribution, reimbursement and information outsourcing services, patient and provider education, data management and outcomes reporting. In addition to historical facts, this press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Matters subject to forward-looking statements involve risks and uncertainties, that could cause actual outcomes and results and the timing of certain events to differ materially from these statements. Risks and uncertainties include without limitation, the Company's dependence on relationships with a limited number of drug manufacturers, reimbursement and payor related risks, risks associated with making acquisitions, application of government laws and regulations and general economic, competitive, and technological risks that may affect the Company's business and prospects. These and other risks and uncertainties are discussed in the Company's filings with the Securities and Exchange Commission. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion